logo

For the Inventor, By the Inventor

Vienna, Austria

Novartis Pharma Gmbh


USPTO Granted Patents = 8

% Expired Patents = 62.5


Forward Citations = 51

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Paul William Manley (2 out of 63 patents)

silverMedal Paul Allen Sutton (2 out of 18 patents)

bronzeMedal Wen-Chung Shieh (2 out of 21 patents)

4.  Raeann Wu (2 out of 12 patents)

5.  Stéphanie Monnier (2 out of 10 patents)

6.  Jörg Brozio (2 out of 7 patents)

7.  Michael Mutz (2 out of 25 patents)

8.  Michael P Cooreman (1 out of 2 patents)

9.  Piotr Henryk Karpinski (1 out of 23 patents)

10.  Hermann Gram (1 out of 19 patents)

11.  Dieter Welzel (1 out of 7 patents)

12.  Franco E Di Padova (1 out of 17 patents)

13.  Thomas Jung (1 out of 9 patents)

14.  Timothy Wright (1 out of 4 patents)

15.  Trevor Mundel (1 out of 3 patents)


8 patents:

1. 8343984 - Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide (2013-01-01),
2. 8198289 - Crystal form H imatinib mesylate for pharmaceutical use (2012-06-12),
3. 8163904 - Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-Benzamide (2012-04-24),
4. 8105587 - Methods of treating arthritis using IL-1β binding molecules (2012-01-31),
5. 8012477 - Methods of treating multiple myeloma using IL-17 binding molecules (2011-09-06),
6. 7998687 - Biomarkers for chronic transplant dysfunction (2011-08-16),
7. 7893076 - Crystalline form F of Imatinib mesylate (2011-02-22),
8. 6740672 - Use of 5HT3-receptor antagonists for the treatment of chronic fatigue syndrome (2004-05-25),
Company Overview
Novartis Pharma GmbH is a subsidiary of Novartis AG, a global healthcare company that provides solutions to address the evolving needs of patients worldwide. Novartis Pharma GmbH focuses on innovative medicines, offering a wide range of products across multiple therapeutic areas such as oncology, cardiovascular, and neuroscience. The company is committed to research and development to improve health outcomes and quality of life for patients.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

8 Patents

#87 in Vienna

#382 in Austria

Vienna, AT
Vienna, Austria

Novartis Pharma Gmbh

Forward Citations = 51

18 inventors:

goldMedal Paul William Manley (2 out of 63 patents)

silverMedal Paul Allen Sutton (2 out of 18 patents)

bronzeMedal Wen-Chung Shieh (2 out of 21 patents)

4.  Raeann Wu (2 out of 12 patents)

5.  Stéphanie Monnier (2 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Novartis Pharma Gmbh. Retrieved from https://idiyas.com/company/novartis-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…